Market Synopsis
The global market for In Vitro Diagnostics (IVD) was valued at USD 98.00 Billion in 2021 and is anticipated to achieve a revenue compound annual growth rate (CAGR) of 2.3% during the forecast period. This growth can be attributed to the rising prevalence of chronic illnesses and significant investments made in the development of automated IVD systems that can provide accurate, timely, and reliable diagnoses in laboratory and hospital settings.IVDs are medical devices that use reagents and assays to identify medical conditions in a laboratory environment. These devices are useful in examining patient tissue and bodily fluid samples, and are compatible with a range of procedures, including hematological, immunological, molecular, and tissue diagnostics. They are also used to identify various medical conditions, such as heart problems, cancer, and infectious diseases.
The IVD market is growing at an unprecedented rate, with OEMs and contract manufacturers focused on developing next-generation diagnostic instruments that are more efficient, user-friendly, and dependable to meet the increasing demand for complex and efficient IVD equipment in areas such as immunoassay, clinical chemistry, hematology, molecular diagnostics, and infectious disease applications. OEMs are also searching for solutions to safeguard their income stream as reagents become more specialized. Additionally, IVD equipment is frequently used by under-trained operators closer to the Point of Care (POC), and as such, new equipment designs must prioritize ease of use, safety, and error prevention.
The advent of nano-biotechnology and biochips, as well as the miniaturization of microfluidic tools, are other factors driving revenue growth in the IVD market during the forecast period. Nanomaterials are being utilized as nanoprobes for diagnosis and bioanalysis, and nanotechnology-based systems have the potential to enable the development of POC testing platforms with robust, portable, and affordable properties to detect infectious diseases, which can be cost-effectively deployed in emerging economies. Furthermore, nanodiagnostics is opening up profitable opportunities for market players as it enables rapid detection of infectious diseases.
Market Dynamics
Driver: Technological Advancements in IVD Products and Services
In vitro diagnostics (IVD) technology has seen the integration of Artificial Intelligence (AI) and Internet of Things (IoT). AI's advanced data analytics and error minimization benefits IVD devices while IoT technology helps with remote device monitoring, administration, and uptime efficiency, enabling patients to access medical information via their smart devices. Moreover, the demand for Point-of-Care (PoC) facilities is on the rise, which is another factor contributing to the growth of the IVD market. Majority of PoC testing equipment consists of handheld electronics or Lateral Flow Immunoassay (LFIA) platform-based molecular collecting techniques. LFIA platforms are known for their accuracy and efficacy, which is improved by using smart devices for better security, precision, and user-friendliness. Biosensors are another PoC testing tool that is becoming more sensitive over time, with blood glucose monitors being a popular example.Restraint: Stringent Regulatory Policies
The growth of the global IVD market is hampered by several unfavorable factors, including the time-consuming diagnostic device and test regulatory approval processes. The regulatory approval process involves a review of clinical data, calibration, manufacturing procedures, quality control, risk assessment, and other aspects to ensure the safety of devices. However, the complexity of molecular diagnostic equipment is a major factor restraining the revenue growth of the market.Some Key Takeaways
Product Type Overview:
The global In Vitro Diagnostics (IVD) market is divided into instruments, reagents & kits, services, and others based on product type. The reagents & kits segment is expected to have the largest share of revenue during the forecast period. The demand for accurate, sensitive, and quick equipment for in-vitro diagnostic testing, self-testing, point-of-care product usage, and reagent-related R&D initiatives is driving this growth. IVD procedures utilize IVD reagents for patient diagnosis, monitoring, and treatment, and these reagents are designed to be used in evaluating human body specimen samples. They can also be used in a variety of instruments, ranging from basic laboratory equipment to compact, portable tests.The instruments segment is expected to have a high growth rate during the forecast period. Medical tools used to conduct tests on samples of body materials, such as tissues, blood, urine, and stool, to identify diseases and infections are known as instruments used in in-vitro diagnostics (IVD). Instruments may include control materials, kits, apparatuses, pieces of equipment, devices, or systems that are used alone or in combination when examining specimens such as donated blood and tissues from the human body.
Technology Overview:
Based on technology, the global In Vitro Diagnostics (IVD) market is divided into immunochemistry, molecular diagnostics, hematology, microbiology, and others. The immunochemistry segment is expected to have a high growth rate during the forecast period. Immunochemistry is a technique that uses antibodies to label and detect biomolecules in applications such as ELISA, immunocytochemistry, and immunohistochemistry. Immunochemistry is currently a recognized ancillary method for the detection of lung cancer. It also aids in the morphological diagnosis of malignancy, determines cell lineage, identifies the primary site of tumor formation, and influences prognosis and therapy choices.Molecular diagnostics are increasingly being used to assist in patient management, from diagnosis to treatment, in fields such as infectious disease, cancer, and congenital abnormalities. The rapid development of molecular techniques in clinical laboratories is a result of the rising demand for genomic and genetic information. In addition to screening and detecting viruses, molecular diagnostics are being used for treatment guidance and monitoring.
Application Overview:
The global In Vitro Diagnostics (IVD) market is divided into infectious diseases, cancer, cardiac diseases, immune system disorders, HIV/AIDS, and others based on application. The infectious disease segment is expected to have a high growth rate during the forecast period, as there is an increase in infectious diseases such as HIV, Sexually Transmitted Diseases (STDs), and tuberculosis.End-Use Overview:
Based on end-use, the global In Vitro Diagnostics (IVD) market is divided into clinical laboratories, academic and medical schools, point-of-care testing centers, hospitals, and others. The hospitals segment accounted for the largest share of revenue in 2021. This is due to the increasing number of patients visiting hospitals, as doctors need to analyze diagnostic tests before starting therapy. Hospitals and diagnostic facilities typically work together, and therefore hospitals often have their own diagnostic setup. Furthermore, the revenue growth of this segment is driven by an increased focus on the development of healthcare infrastructure, which is likely to upgrade current hospital facilities.Regional Outlook:
Regional analysis shows that North America is expected to have the largest revenue share in the In Vitro Diagnostics (IVD) market over the forecast period. This can be attributed to the region's increasing awareness of diagnostic devices, the presence of established healthcare companies, a rising incidence of chronic ailments, and a geriatric population in countries such as the U.S.The Asia Pacific market is expected to have a significant revenue Compound Annual Growth Rate (CAGR) over the forecast period. This is due to an increasing number of people becoming aware of healthcare issues in this region and seeking early diagnoses. In addition, the large patient population, an increase in chronic diseases requiring IVD testing, and enhanced healthcare facilities are expected to drive revenue growth in the market.
The Europe market is expected to have a steady revenue CAGR over the forecast period. This is due to the growing use of point-of-care diagnostics tests and a rising incidence of various chronic diseases in the region. Furthermore, an increased susceptibility to infections and age-related diseases, resulting from low immunogenicity and a growing geriatric population, adds to the burden of infectious diseases, driving revenue growth of the in-vitro diagnostics market in this region.
Competitive Landscape:
The global market for In Vitro Diagnostics (IVD) is moderately consolidated with a few major companies operating on both global and regional levels. These companies are focused on product development and strategic partnerships to expand their product portfolios and increase their presence in the global market. Some of the major companies operating in the market include Abbott, Bio-Rad Laboratories, BIOMÉRIEUX, Thermo Fisher Scientific, Agilent Technologies, F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics, Sysmex, Quidel Corporation, and Charles River Laboratories.Several recent developments have occurred in the market, such as the partnership between BioMérieux and BrightInsight, Inc. to develop and market a Clinical Digital Solution for diagnostics that provides clinical decision support for disease areas across their diagnostic tests. In addition, Illumina launched a new in vitro diagnostic test in Europe to characterize various cancer mutations and guide patients to tailored medicines. Invitae has also launched FusionPlex Dx and LiquidPlex Dx in Europe, which are part of the company's market-leading Anchored Multiplex PCR Chemistry IVD line, providing crucial innovation for precision oncology. These recent developments reflect the competitive landscape of the IVD market and the ongoing efforts of major companies to innovate and expand their offerings.
Table of Contents
Chapter 1. Market Synopsis1.1. Market Definitions
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2022-2030
Chapter 3. Indicative Metrics
Chapter 4. In Vitro Diagnostics (IVD) Market Segmentation & Impact Analysis
4.1. In Vitro Diagnostics (IVD) Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers’ analysis
4.2.2.1. Increase in occurrence of infectious and chronic diseases
4.2.2.2. Demand for PoC facilities growing
4.2.2.3. Technological breakthroughs in IVD services, tools, and products
4.2.3. Market restraints analysis
4.2.3.1. Increased device cost
4.2.3.2. Strict regulatory policies
4.2.3.3. Complexity of molecular diagnostic equipment
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price Trend Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact Analysis
4.11. Global Recession Influence
Chapter 5. In Vitro Diagnostics (IVD) Market By Product Type Insights & Trends
5.1. Product Type Dynamics & Market Share, 2022 & 2030
5.2. Instruments
5.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
5.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
5.3. Reagents & Kits
5.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
5.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
5.4. Services
5.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
5.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
5.5. Others
5.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
5.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
Chapter 6. In Vitro Diagnostics (IVD) Market By Technology Insights & Trends
6.1. Technology Dynamics & Market Share, 2022 & 2030
6.2. Immunochemistry
6.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
6.3. Molecular Diagnostics
6.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
6.4. Hematology
6.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
6.5. Microbiology
6.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
6.6. Others
6.6.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
6.6.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
Chapter 7. In Vitro Diagnostics (IVD) Market By Application Insights & Trends
7.1. Application Dynamics & Market Share, 2022 & 2030
7.2. Infectious Diseases
7.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
7.3. Cancer
7.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
7.4. Cardiac Diseases
7.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
7.5. Immune System Disorders
7.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
7.6. HIV/AIDS
7.6.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.6.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
7.7. Others
7.7.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
7.7.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
Chapter 8. In Vitro Diagnostics (IVD) Market By End-use Insights & Trends
8.1. End-Use Dynamics & Market Share, 2022 & 2030
8.2. Clinical Laboratories
8.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
8.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
8.3. Academic and Medical Schools
8.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
8.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
8.4. Point-of-Care Testing Centers
8.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
8.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
8.5. Hospitals
8.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
8.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
8.6. Others
8.6.1. Market estimates and forecast, 2019 - 2030 (USD Billion)
8.6.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion)
Chapter 9. In Vitro Diagnostics (IVD) Market Regional Outlook
9.1. In Vitro Diagnostics (IVD) Market share By Region, 2022 & 2030
9.2. North America
9.2.1. North America In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.2.2. North America In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.2.3. North America In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.2.4. North America In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.2.5. North America In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.2.6. U.S.
9.2.6.1. U.S. In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.2.6.2. U.S. In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.2.6.3. U.S. In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.2.6.4. U.S. In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.2.6.5. U.S. In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.2.7. Canada
9.2.7.1. Canada In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.2.7.2. Canada In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.2.7.3. Canada In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.2.7.4. Canada In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.2.7.5. Canada In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.2.8. Mexico
9.2.8.1. Mexico In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.2.8.2. Mexico In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.2.8.3. Mexico In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.2.8.4. Mexico In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.2.8.5. Mexico In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3. Europe
9.3.1. Europe In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.2. Europe In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.3. Europe In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.4. Europe In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.5. Europe In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3.6. Germany
9.3.6.1. Germany In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.6.2. Germany In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.6.3. Germany In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.6.4. Germany In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.6.5. Germany In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3.7. UK
9.3.7.1. UK In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.7.2. UK In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.7.3. UK In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.7.4. UK In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.7.5. UK In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3.8. France
9.3.8.1. France In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.8.2. France In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.8.3. France In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.8.4. France In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.8.5. France In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3.9. Italy
9.3.9.1. Italy In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.9.2. Italy In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.9.3. Italy In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.9.4. Italy In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.9.5. Italy In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3.10. Spain
9.3.10.1. Spain In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.10.2. Spain In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.10.3. Spain In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.10.4. Spain In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.10.5. Spain In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3.11. Sweden
9.3.11.1. Sweden In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.11.2. Sweden In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.11.3. Sweden In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.11.4. Sweden In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.11.5. Sweden In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3.12. BENELUX
9.3.12.1. BENELUX In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.12.2. BENELUX In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.12.3. BENELUX In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.12.4. BENELUX In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.12.5. BENELUX In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.3.13. Rest of Europe
9.3.13.1. Rest of Europe In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.3.13.2. Rest of Europe In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.3.13.3. Rest of Europe In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.3.13.4. Rest of Europe In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.3.13.5. Rest of Europe In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.4. Asia Pacific
9.4.1. Asia Pacific In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.4.2. Asia Pacific In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.4.3. Asia Pacific In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.4.4. Asia Pacific In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.4.5. Asia Pacific In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.4.6. China
9.4.6.1. China In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.4.6.2. China In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.4.6.3. China In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.4.6.4. China In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.4.6.5. China In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.4.7. India
9.4.7.1. India In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.4.7.2. India In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.4.7.3. India In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.4.7.4. India In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.4.7.5. India In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.4.8. Japan
9.4.8.1. Japan In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.4.8.2. Japan In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.4.8.3. Japan In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.4.8.4. Japan In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.4.8.5. Japan In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.4.9. South Korea
9.4.9.1. South Korea In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.4.9.2. South Korea In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.4.9.3. South Korea In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.4.9.4. South Korea In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.4.9.5. South Korea In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.4.10. Rest of APAC
9.4.10.1. Rest of APAC In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.4.10.2. Rest of APAC In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.4.10.3. Rest of APAC In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.4.10.4. Rest of APAC In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.4.10.5. Rest of APAC In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.5. Latin America
9.5.1. Latin America In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.5.2. Latin America In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.5.3. Latin America In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.5.4. Latin America In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.5.5. Latin America In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.5.6. Brazil
9.5.6.1. Brazil In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.5.6.2. Brazil In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.5.6.3. Brazil In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.5.6.4. Brazil In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.5.6.5. Brazil In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.5.7. Rest of LATAM
9.5.7.1. Rest of LATAM In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.5.7.2. Rest of LATAM In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.5.7.3. Rest of LATAM In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.5.7.4. Rest of LATAM In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.5.7.5. Rest of LATAM In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.6. Middle East & Africa
9.6.1. Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.6.2. Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.6.3. Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.6.4. Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.6.5. Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.6.6. Saudi Arabia
9.6.6.1. Saudi Arabia In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.6.6.2. Saudi Arabia In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.6.6.3. Saudi Arabia In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.6.6.4. Saudi Arabia In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.6.6.5. Saudi Arabia In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.6.7. UAE
9.6.7.1. UAE In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.6.7.2. UAE In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.6.7.3. UAE In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.6.7.4. UAE In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.6.7.5. UAE In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.6.8. South Africa
9.6.8.1. South Africa In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.6.8.2. South Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.6.8.3. South Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.6.8.4. South Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.6.8.5. South Africa In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.6.9. Israel
9.6.9.1. Israel In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.6.9.2. Israel In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.6.9.3. Israel In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.6.9.4. Israel In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.6.9.5. Israel In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
9.6.10. Rest of Middle East & Africa
9.6.10.1. Rest of Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast, 2019 - 2030, (USD Billion)
9.6.10.2. Rest of Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Product Type, 2019 - 2030, (USD Billion)
9.6.10.3. Rest of Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Technology, 2019 - 2030, (USD Billion)
9.6.10.4. Rest of Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast By Application, 2019 - 2030, (USD Billion)
9.6.10.5. Rest of Middle East & Africa In Vitro Diagnostics (IVD) Market estimates and forecast By End-Use, 2019 - 2030, (USD Billion)
Chapter 10. Competitive Landscape
10.1. Market Revenue Share By Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Market Positioning
10.5. Strategy Benchmarking
10.6. Vendor Landscape
Chapter 11. Company Profiles
11.1. Abbott
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Technology Insights
11.1.4. Strategic Initiatives
11.2. Bio-Rad Laboratories, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Technology Insights
11.2.4. Strategic Initiatives
11.3. BIOMÉRIEUX
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Technology Insights
11.3.4. Strategic Initiatives
11.4. Thermo Fisher Scientific
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Technology Insights
11.4.4. Strategic Initiatives
11.5. Agilent Technologies, Inc
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Technology Insights
11.5.4. Strategic Initiatives
11.6. F. Hoffmann-La Roche Ltd.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Technology Insights
11.6.4. Strategic Initiatives
11.7. Ortho Clinical Diagnostics
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Technology Insights
11.7.4. Strategic Initiatives
11.8. Sysmex
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Technology Insights
11.8.4. Strategic Initiatives
11.9. Quidel Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Technology Insights
11.9.4. Strategic Initiatives
11.10. Charles River Laboratories
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Technology Insights
11.10.4. Strategic Initiatives
Companies Mentioned
- Abbott
- Bio-Rad Laboratories Inc.
- BIOMÉRIEUX
- Thermo Fisher Scientific
- Agilent Technologies Inc.
- F. Hoffmann-La Roche Ltd.
- Ortho Clinical Diagnostics
- Sysmex
- Quidel Corporation
- Charles River Laboratories.
